Arcellx Inc (ACLX)
82.76
-1.38
(-1.64%)
USD |
NASDAQ |
Sep 27, 16:00
82.73
-0.03
(-0.04%)
After-Hours: 20:00
Arcellx Total Return Level: 82.76 for Sept. 27, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
September 27, 2024 | 82.76 |
September 26, 2024 | 84.14 |
September 25, 2024 | 84.60 |
September 24, 2024 | 84.44 |
September 23, 2024 | 85.98 |
September 20, 2024 | 86.61 |
September 19, 2024 | 85.43 |
September 18, 2024 | 80.55 |
September 17, 2024 | 77.99 |
September 16, 2024 | 77.01 |
September 13, 2024 | 76.89 |
September 12, 2024 | 74.77 |
September 11, 2024 | 74.40 |
September 10, 2024 | 74.19 |
September 09, 2024 | 74.27 |
September 06, 2024 | 71.25 |
September 05, 2024 | 70.37 |
September 04, 2024 | 65.46 |
September 03, 2024 | 66.12 |
August 30, 2024 | 68.74 |
August 29, 2024 | 67.48 |
August 28, 2024 | 69.30 |
August 27, 2024 | 71.47 |
August 26, 2024 | 71.90 |
August 23, 2024 | 69.38 |
Date | Value |
---|---|
August 22, 2024 | 66.46 |
August 21, 2024 | 66.64 |
August 20, 2024 | 65.89 |
August 19, 2024 | 66.37 |
August 16, 2024 | 65.28 |
August 15, 2024 | 64.86 |
August 14, 2024 | 60.27 |
August 13, 2024 | 60.64 |
August 12, 2024 | 58.94 |
August 09, 2024 | 59.05 |
August 08, 2024 | 52.58 |
August 07, 2024 | 50.91 |
August 06, 2024 | 51.73 |
August 05, 2024 | 51.09 |
August 02, 2024 | 55.31 |
August 01, 2024 | 58.65 |
July 31, 2024 | 61.81 |
July 30, 2024 | 61.67 |
July 29, 2024 | 62.10 |
July 26, 2024 | 64.41 |
July 25, 2024 | 62.69 |
July 24, 2024 | 62.10 |
July 23, 2024 | 63.16 |
July 22, 2024 | 62.97 |
July 19, 2024 | 62.56 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
7.21
Minimum
May 18 2022
86.61
Maximum
Sep 20 2024
37.38
Average
33.84
Median
Jul 18 2023
Total Return Level Benchmarks
Johnson & Johnson | 526.51 |
NovaBay Pharmaceuticals Inc | 0.71 |
Palatin Technologies Inc | 0.8406 |
iBio Inc | 2.08 |
Theriva Biologics Inc | 1.49 |